XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Sep. 30, 2017
Dec. 31, 2016
Current Assets    
Cash and cash equivalents $ 7,901 $ 6,515
Short-term investments 3,294 7,826
Accounts receivable (net of allowance for doubtful accounts of $222 in 2017 and $195 in 2016) 7,671 7,018
Inventories (excludes inventories of $1,029 in 2017 and $1,117 in 2016 classified in Other assets - see Note 5) 5,263 4,866
Other current assets 3,790 4,389
Total current assets 27,919 30,614
Investments 12,206 11,416
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,661 in 2017 and $15,749 in 2016 12,189 12,026
Goodwill 18,340 18,162
Other Intangibles, Net 15,138 17,305
Other Assets 5,884 5,854
Total Assets 91,676 95,377
Current Liabilities    
Loans payable and current portion of long-term debt 5,157 568
Trade accounts payable 2,620 2,807
Accrued and other current liabilities 9,992 10,274
Income taxes payable 396 2,239
Dividends payable 1,302 1,316
Total current liabilities 19,467 17,204
Long-Term Debt 21,838 24,274
Deferred Income Taxes 4,159 5,077
Other Noncurrent Liabilities 7,713 8,514
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016 1,788 1,788
Other paid-in capital 39,823 39,939
Retained earnings 43,701 44,133
Accumulated other comprehensive loss (4,945) (5,226)
Stockholders' equity before deduction for treasury stock 80,367 80,634
Less treasury stock, at cost: 850,698,697 shares in 2017 and 828,372,200 shares in 2016 42,119 40,546
Total Merck & Co., Inc. stockholders’ equity 38,248 40,088
Noncontrolling Interests 251 220
Total equity 38,499 40,308
Liabilities and Equity $ 91,676 $ 95,377